Odyssey’s IPO Brings In $304M for Quest to Develop Better Immunology Drugs
Ulcerative colitis is the lead indication for Odyssey Therapeutics’ internally found lead drug candidate. With the IPO proceeds, Odyssey plans ...
Ulcerative colitis is the lead indication for Odyssey Therapeutics’ internally found lead drug candidate. With the IPO proceeds, Odyssey plans ...
Allison DeAngelis is the East Coast biotech and enterprise capital reporter at STAT, reporting the place scientific concepts and cash ...
Researchers led by Xian-Yang Qin on the RIKEN Heart for Integrative Medical Sciences (IMS) in Japan have developed a rating ...
Researchers have developed experimental drugs that encourage the mitochondria in our cells to work a little harder and burn more ...
The microscopic organisms that fill our bodies, soils, oceans and atmosphere play essential roles in human health and the planet's ...
Women’s brain health is having a long-overdue moment. For Emma Heming Willis and Helen Christoni, it isn’t just a wellness ...
In the quest to address infertility, Cornell University researchers have developed a groundbreaking device that could simplify and automate oocyte ...
Develop Health, a benefits verification and prior authorization platform, has raised $14.3 million in Series A funding, the company announced ...
Immunofluorescent staining for macrophages (CD68, green) and nuclei (DAPI, blue) on the hydrogel-tissue interface seven days after artery incisions in ...
The next wave of metabolic medicines in development includes oral GLP-1 drugs that work comparably to currently available injectable medicines, ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.